Blueprint Medicines Corp Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Blueprint Medicines Corp for March 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 1,000 | 36,050 | 3,591 | |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 104.65 | 322 | 33,697 | 53,948 | 54.3 K to 53.9 K (-0.59 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 105.44 | 426 | 44,917 | 54,270 | 54.7 K to 54.3 K (-0.78 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 106.62 | 108 | 11,515 | 54,696 | 54.8 K to 54.7 K (-0.20 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 107.42 | 138 | 14,824 | 54,804 | 54.9 K to 54.8 K (-0.25 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 108.16 | 6 | 649 | 54,942 | 54.9 K to 54.9 K (-0.01 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 1,000 | 36,050 | 54,948 | 53.9 K to 54.9 K (+1.85 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Option Exercise | M | 36.05 | 1,000 | 36,050 | 3,591 | |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 104.65 | 322 | 33,697 | 53,948 | 54.3 K to 53.9 K (-0.59 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 105.44 | 426 | 44,917 | 54,270 | 54.7 K to 54.3 K (-0.78 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 106.62 | 108 | 11,515 | 54,696 | 54.8 K to 54.7 K (-0.20 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 107.42 | 138 | 14,824 | 54,804 | 54.9 K to 54.8 K (-0.25 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 108.16 | 6 | 649 | 54,942 | 54.9 K to 54.9 K (-0.01 %) |
| Mar 17 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Buy | M | 36.05 | 1,000 | 36,050 | 54,948 | 53.9 K to 54.9 K (+1.85 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Sell | S | 86.61 | 1,584 | 137,190 | 30,874 | 32.5 K to 30.9 K (-4.88 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Sell | S | 88.96 | 109 | 9,697 | 32,458 | 32.6 K to 32.5 K (-0.33 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 86.61 | 804 | 69,634 | 11,799 | 12.6 K to 11.8 K (-6.38 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 89.24 | 53 | 4,730 | 12,603 | 12.7 K to 12.6 K (-0.42 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 98.45 | 515 | 50,702 | 12,656 | 13.2 K to 12.7 K (-3.91 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 86.61 | 1,828 | 158,323 | 53,948 | 55.8 K to 53.9 K (-3.28 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Operating Off ... | Sell | S | 89.09 | 124 | 11,047 | 55,776 | 55.9 K to 55.8 K (-0.22 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Landsittel Michael | Chief Financial Off ... | Sell | S | 86.61 | 1,411 | 122,207 | 28,905 | 30.3 K to 28.9 K (-4.65 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Landsittel Michael | Chief Financial Off ... | Sell | S | 88.98 | 96 | 8,542 | 30,316 | 30.4 K to 30.3 K (-0.32 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Sell | S | 86.61 | 1,772 | 153,473 | 32,852 | 34.6 K to 32.9 K (-5.12 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Sell | S | 89.00 | 121 | 10,769 | 34,624 | 34.7 K to 34.6 K (-0.35 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Murray Christopher K. | SVP, Technical Oper ... | Sell | S | 86.61 | 1,133 | 98,129 | 18,888 | 20 K to 18.9 K (-5.66 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Murray Christopher K. | SVP, Technical Oper ... | Sell | S | 89.02 | 77 | 6,855 | 20,021 | 20.1 K to 20 K (-0.38 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Sell | S | 86.61 | 1,272 | 110,168 | 31,723 | 33 K to 31.7 K (-3.86 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Sell | S | 89.10 | 87 | 7,752 | 32,995 | 33.1 K to 33 K (-0.26 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 8.80 | 10,000 | 88,000 | 7,170 | |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 86.61 | 8,417 | 728,996 | 172,448 | 180.9 K to 172.4 K (-4.65 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 88.63 | 569 | 50,430 | 180,865 | 181.4 K to 180.9 K (-0.31 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 86.61 | 100 | 8,661 | 181,434 | 181.5 K to 181.4 K (-0.06 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 89.18 | 100 | 8,918 | 181,534 | 181.6 K to 181.5 K (-0.06 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 90.18 | 404 | 36,433 | 181,634 | 182 K to 181.6 K (-0.22 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 90.99 | 3,000 | 272,970 | 182,038 | 185 K to 182 K (-1.62 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 91.78 | 5,296 | 486,067 | 185,038 | 190.3 K to 185 K (-2.78 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 93.21 | 1,100 | 102,531 | 190,334 | 191.4 K to 190.3 K (-0.57 %) |
| Mar 05 2021 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 8.80 | 10,000 | 88,000 | 191,434 | 181.4 K to 191.4 K (+5.51 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Option Exercise | A | 100.13 | 26,125 | 2,615,896 | 26,125 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Rossi Christina | Chief Commercial Of ... | Grant | A | 0.00 | 13,062 | 0 | 33,082 | 20 K to 33.1 K (+65.24 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Option Exercise | A | 100.13 | 26,125 | 2,615,896 | 26,125 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Durso-Bumpus Debra | Chief People Office ... | Grant | A | 0.00 | 13,062 | 0 | 32,567 | 19.5 K to 32.6 K (+66.97 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Murray Christopher K. | SVP, Technical Oper ... | Option Exercise | A | 100.13 | 12,500 | 1,251,625 | 12,500 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Murray Christopher K. | SVP, Technical Oper ... | Grant | A | 0.00 | 6,250 | 0 | 20,098 | 13.8 K to 20.1 K (+45.13 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 8.80 | 300 | 2,640 | 2,664 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | M | 1.87 | 1,400 | 2,618 | 5,754 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Option Exercise | A | 100.13 | 6,375 | 638,329 | 6,375 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Sell | S | 99.51 | 1,700 | 169,167 | 13,171 | 14.9 K to 13.2 K (-11.43 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 8.80 | 300 | 2,640 | 14,871 | 14.6 K to 14.9 K (+2.06 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Buy | M | 1.87 | 1,400 | 2,618 | 14,571 | 13.2 K to 14.6 K (+10.63 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hurley Ariel | Principal Accountin ... | Grant | A | 0.00 | 3,187 | 0 | 13,171 | 10 K to 13.2 K (+31.92 %) |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hewes L. Becker | Chief Medical Offic ... | Option Exercise | A | 100.13 | 26,125 | 2,615,896 | 26,125 | |
| Mar 03 2021 | BPMC | Blueprint Medicine ... | Hewes L. Becker | Chief Medical Offic ... | Grant | A | 0.00 | 13,062 | 0 | 30,562 | 17.5 K to 30.6 K (+74.64 %) |